Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Trepo

Showing results (321-330 of 334) with videos related to

Pageof 34
Sort By:
Antimicrobial Agents and Chemotherapy|June 25, 2004
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infectionA C Jacquard, M Nassal, C Pichoud, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
HIV Medicine|May 14, 2004
The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000A Gayet-Ageron, D Baratin, E Marceillac, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis CT Fontanges, F Bailly, E Trepo, et al.
Ugeskrift for Laeger|October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Medical Virology|November 14, 2000
Serological pattern "anti-HBc alone": report on a workshopP Grob, W Jilg, H Bornhak, et al.
Journal of Hepatology|December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial GroupK Krogsgaard, P Marcellin, C Trepo, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
British Journal of Cancer|June 26, 2008
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinomaA Bengochea, M M de Souza, L Lefrançois, et al.
Journal of Viral Hepatitis|July 22, 2014
HBV/HDV co-infection in the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriersA Kay, E Melo da Silva, H Pedreira, et al.
Pageof 34

Showing results (321-330 of 334) with videos related to

Sort By:
Pageof 34
Antimicrobial Agents and Chemotherapy|June 25, 2004
Effect of a combination of clevudine and emtricitabine with adenovirus-mediated delivery of gamma interferon in the woodchuck model of hepatitis B virus infectionA C Jacquard, M Nassal, C Pichoud, et al.
Hepatology (Baltimore, Md.)|August 2, 2001
A randomized, double-blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis CK L Lindsay, C Trepo, T Heintges, et al.
HIV Medicine|May 14, 2004
The AIDS epidemic in Lyon: patient characteristics and defining illnesses between 1985 and 2000A Gayet-Ageron, D Baratin, E Marceillac, et al.
Gastroenterologie Clinique Et Biologique|September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis CT Fontanges, F Bailly, E Trepo, et al.
Ugeskrift for Laeger|October 15, 1998
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]K Krogsgaard, P Marcellin, C Trepo, et al.
Journal of Medical Virology|November 14, 2000
Serological pattern "anti-HBc alone": report on a workshopP Grob, W Jilg, H Bornhak, et al.
Journal of Hepatology|December 1, 1996
Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. INTERPRED Trial GroupK Krogsgaard, P Marcellin, C Trepo, et al.
Alimentary Pharmacology & Therapeutics|March 28, 2008
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis BS G Lim, N Leung, H W L Hann, et al.
British Journal of Cancer|June 26, 2008
Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinomaA Bengochea, M M de Souza, L Lefrançois, et al.
Journal of Viral Hepatitis|July 22, 2014
HBV/HDV co-infection in the Western Brazilian Amazonia: an intriguing mutation among HDV genotype 3 carriersA Kay, E Melo da Silva, H Pedreira, et al.
Pageof 34